Mar 01,2022

ASCENSIA DIABETES CARE LAUNCHES THE EVERSENSE NOW REMOTE MONITORING APP FOR ANDROID USERS IN EUROPE

Ascensia Diabetes Care, a global diabetes care company, announces that it has launched the Eversense® NOW Remote Monitoring App for the Android Operating System in Europe. With this launch, remote monitoring capabilities are now available for all Eversense® and Eversense® XL Continuous Glucose Monitoring (CGM) users on Android and iOS operating systems in the US and Europe, respectively.

PRODUCT

#mobile app

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis

This study aims to estimate the budget impact of increased uptake of the FreeStyle Libre Flash Glucose Monitoring system in people with type 1 diabetes mellitus (T1DM) in the UK.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 02,2022

Dexcom wins FDA breakthrough nod for use of its CGM in hospitals

Dexcom (NSDQ:DXCM) announced that it received FDA breakthrough device designation for the use of its CGM in a hospital setting. The FDA early in the COVID-19 pandemic issued temporary guidance allowing increased remote monitoring of hospital patients in order to limit contact with hospital staff.

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 07,2022

Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program

Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM), is pleased to announce that effective March 14 2022, the Ontario government will provide coverage for the Dexcom G6 CGM System through Ontario’s Assistive Devices Program (ADP) for people in the province living with type 1 diabetes who are over 2 years of age and meet coverage criteria.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 07,2022

Real-World Use of Continuous Glucose Monitoring (CGM) Systems Among Adolescents and Young Adults With Type 1 Diabetes: Reduced Burden, but Little Interest in Data Analysis

Since 2016, German health insurance companies reimburse continuous glucose monitoring (CGM) systems for persons with insulin-dependent diabetes, leading to a tremendous increase of CGM use. This study assessed the use of CGM, the satisfaction with, and the data analysis behavior among young people.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 14,2022

Medtronic announces recent reimbursement wins for CGMs in a number of geographies

Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for continuous glucose monitoring (CGM), a key diabetes technology has been recently expanded or initiated in several countries throughout North and South America.

PRODUCT

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Mar 14,2022

Predicting Glycated Hemoglobin Through Continuous Glucose Monitoring in Real-Life Conditions: Improved Estimation Methods

The adoption of continuous glucose monitoring (CGM) already helps to improve glycemic control in diabetes. When coupled with appropriate data analysis techniques, CGM also provides dependable estimates for significant metrics, like glycated hemoglobin (HbA1c).

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 14,2022

Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 16,2022

Diabetes tech is off to a hot start in 2022

Change is continuous in continuous glucose monitoring (GCM), with expanded wear-times, improved accuracy and more. Meanwhile, never-ending innovation in insulin delivery is delivering wearable patches and closedloop delivery systems, making insulin management easier for people with diabetes.

#cgm

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Mar 18,2022

How the hospital may become a new market for CGMs

Following a breakthrough nod for Dexcom, CGMs may become a key part of hospital care.

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to CGM